v3.26.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common shares
Additional  Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   174,661,943      
Beginning balance, value at Dec. 31, 2024 $ 2,389,611 $ 1,740 $ 1,945,261 $ 1,236,696 $ (794,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares on exercise of options (in shares)   95,920      
Issuance of common shares on exercise of options (Note 15) 4,072 $ 1 4,071    
Issuance of common shares under the employee stock purchase plan (in shares)   59,945      
Issuance of common shares under the employee stock purchase plan (Note 15) 2,871 $ 1 2,870    
Net settlement on vesting of restricted share unit (in shares)   522,905      
Net settlement on vesting of restricted share units (Note 15) (12,749) $ 5 (12,754)    
Net settlement on vesting of performance units (in shares)   737,027      
Net settlement on vesting of performance units (Note 15) $ (17,999) $ 7 (18,006)    
Stock repurchased and retired (in shares) (1,206,812) (1,206,812)      
Stock repurchased and retired (Note 16) $ (62,963) $ (12)   (62,951)  
Expenses and taxes related to stock repurchased (Note 16) (24)     (24)  
Stock-based compensation expense (Note 15) 20,036   20,036    
Comprehensive income (loss):          
Net income 130,853     130,853  
Other comprehensive income (loss) 29,137       29,137
Dividend (29,784)     (29,784)  
End balance (in shares) at Mar. 31, 2025   174,870,928      
End balance, value at Mar. 31, 2025 $ 2,453,061 $ 1,742 1,941,478 1,274,790 (764,949)
Beginning balance (in shares) at Dec. 31, 2025 170,341,479 170,341,479      
Beginning balance, value at Dec. 31, 2025 $ 2,549,401 $ 1,696 2,018,985 1,390,164 (861,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares on exercise of options (in shares) 2,800 2,800      
Issuance of common shares on exercise of options (Note 15) $ 77   77    
Issuance of common shares under the employee stock purchase plan (in shares)   76,679      
Issuance of common shares under the employee stock purchase plan (Note 15) 2,741 $ 1 2,740    
Net settlement on vesting of restricted share unit (in shares)   635,422      
Net settlement on vesting of restricted share units (Note 15) (16,337) $ 6 (16,343)    
Net settlement on vesting of performance units (in shares)   259,792      
Net settlement on vesting of performance units (Note 15) $ (6,141) $ 3 (6,144)    
Stock repurchased and retired (in shares) (1,811,986) (1,811,986)      
Stock repurchased and retired (Note 16) $ (69,956) $ (18)   (69,938)  
Expenses and taxes related to stock repurchased (Note 16) (36)     (36)  
Stock-based compensation expense (Note 15) 22,273   22,273    
Comprehensive income (loss):          
Net income 147,992     147,992  
Other comprehensive income (loss) (123,048)       (123,048)
Dividend (31,773)     (31,773)  
End balance (in shares) at Mar. 31, 2026   169,504,186      
End balance, value at Mar. 31, 2026 $ 2,475,193 $ 1,688 $ 2,021,588 $ 1,436,409 $ (984,492)